ICUI: ICU Medical, Inc. Stock

by  •  • Comments Off on ICUI: ICU Medical, Inc. Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 2,360.98
Enterprise Value ($M) 3,735.52
Book Value ($M) 2,123.41
Book Value / Share 87.15
Price / Book 1.11
NCAV ($M) -1,033.76
NCAV / Share -42.43
Price / NCAV -2.28

Profitability (mra)
Return on Invested Capital (ROIC) -0.01
Return on Assets (ROA) -0.01
Return on Equity (ROE) -0.01

Liquidity (mrq)
Quick Ratio 1.06
Current Ratio 2.53

Balance Sheet (mrq) ($M)
Current Assets 1,221.27
Assets 4,378.44
Liabilities 2,255.03
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2,259.13
Operating Income 47.84
Net Income -29.66
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 166.20
Cash from Investing -87.95
Cash from Financing -35.98

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-01 13D/A Smiths Group Plc 6.90
02-13 13G/A Janus Henderson Group Plc 10.80 2.37
02-13 13G Fuller & Thaler Asset Management, Inc. 6.10
02-08 13G/A Wellington Management Group Llp 6.53 -33.42
01-24 13G/A BlackRock Inc. 10.60 2.20
01-10 13G/A Vanguard Group Inc 10.11 15.99
12-11 13G/A T. Rowe Price Investment Management, Inc. 4.90 -51.57

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SE
2023-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2023
2023-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2023
2023-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2023

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-19 43,121 154,380 27.93
2024-04-18 24,714 63,468 38.94
2024-04-17 21,702 140,242 15.47
2024-04-16 32,133 145,442 22.09
2024-04-15 46,481 208,407 22.30

(click for more detail)

Similar Companies
GEHC – GE HealthCare Technologies Inc. HOLX – Hologic, Inc.
IART – Integra LifeSciences Holdings Corporation INGN – Inogen, Inc.
INMD – InMode Ltd.


Financial data and stock pages provided by
Fintel.io